counter-ion is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-10-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
== Clinical significance == Calcitonin assay is used in identifying patients with nodular thyroid diseases. It is helpful in making an early diagnosis of medullary carcinoma of thyroid. A malignancy of the parafollicular cells, i.e. medullary thyroid cancer (MTC), typically produces an elevated serum calcitonin level. Prognosis of MTC depends on early detection and treatment. Calcitonin also has significantly impacted molecular biology, as the gene encoding calcitonin was the first gene discovered in mammalian cells to be alternatively spliced, now known to be a ubiquitous mechanism in eukaryotes.
Pregabalin is a member of the gabapentinoid class, also known as α2δ ligands. Despite being a structural analog of γ-aminobutyric acid (GABA), pregabalin is inactive at GABA receptors and does not mimic GABA. Instead, its action involves binding to a specific site on the α2δ-1 protein and reducing the release of excitatory neurotransmitters in synapses. Pregabalin does not directly block calcium channels (it is not a calcium channel blocker), as it does not bind to the ion conducting channel protein, called α1. However, in vitro studies show that pregabalin can reduce the normal traffic of calcium channels from intracellular sites (where they do not function) to membrane sites where they are functional. While the mechanism of action of pregabalin is not definitively characterized, its action in animal models of pain, seizures and anxiety requires binding to the α2δ-1 protein. It has been found that this binding inhibits several actions of α2δ-1 and also inhibits the release of excitatory neurotransmitters. These excitatory neurotransmitters include glutamate, norepinephrine (noradrenaline), serotonin, dopamine, substance P, and calcitonin gene-related peptide. By inhibiting the release of these neurotransmitters, pregabalin reduces excess activity of neuron networks, which helps alleviate symptoms and provides relief for patients experiencing pain, seizures, or other related symptoms.
The brief existence of an mRNA molecule begins with transcription, and ultimately ends in degradation. During its life, an mRNA molecule may also be processed, edited, and transported prior to translation. Eukaryotic mRNA molecules often require extensive processing and transport, while prokaryotic mRNA molecules do not. A molecule of eukaryotic mRNA and the proteins surrounding it are together called a messenger RNP.
== Pathophysiology == Coronary occlusion is caused by plaque inside of the blood vessels that direct oxygen rich blood to the heart. Plaque is caused by fatty deposits and scar tissue that cling to the walls of coronary arteries. The development of plaque takes years and leads to stenosis of the coronary arteries and progressively reduces blood flow. Due to the slower development of this condition, the body will adapt and create small blood vessels that circumvent the blockage. The small blood vessels form a natural bypass of the blockage, but often do not supply enough blood to meet an increased demand when stressors are applied like exercise. When a plaque has a greater than 50% diameter stenosis, the reduced blood flow through the coronary artery during exertion may lead to angina. Acute coronary events occur when a thrombus forms due to disruption of a plaque. In acute heart attack, occlusion is greater than in unstable angina, where arterial occlusion is not full blockage. Downstream embolism of thrombus may also produce microinfarcts.
=== Reactive oxygen species generation === Alloxan (C4H2N2O4) readily undergoes redox cycling with its one-electron (C4H3N2O4• semiquinone) and two-electron (dialuric acid, C4H4N2O4) reduction products. In the presence of intracellular reductants such as glutathione (or other thiols), this leads to the generation of toxic reactive oxygen species (ROS) via the interaction of alloxan reduction products with molecular oxygen and related species:
Sources: en.wikipedia.org
Defense against ballistic, hypersonic, advanced cruise missiles, and next-generation aerial attacks Deployment of the Hypersonic and Ballistic Tracking Space Sensor layer Deployment of proliferated space-based interceptors capable of boost-phase intercept Deployment of terminal-phase intercept capabilities to defeat countervalue attacks (Glide Phase Interceptors (GPIs)) Deployment of the Space Development Agency's Proliferated Warfighter Space Architecture custody layer Deployment of capabilities to defeat missile attacks before launch ("left of launch" preemptive strike capabilities) Deployment of a secure supply chain for all components Deployment of non-kinetic capabilities to augment kinetic attacks
In radio and telecommunications, the frequency spectrum can be shared among many different broadcasters. The radio spectrum is the part of the electromagnetic spectrum corresponding to frequencies lower below 300 GHz, which corresponds to wavelengths longer than about 1 mm. The microwave spectrum corresponds to frequencies between 300 MHz (0.3 GHz) and 300 GHz and wavelengths between one meter and one millimeter. Each broadcast radio and TV station transmits a wave on an assigned frequency range, called a channel. When many broadcasters are present, the radio spectrum consists of the sum of all the individual channels, each carrying separate information, spread across a wide frequency spectrum. Any particular radio receiver will detect a single function of amplitude (voltage) vs. time. The radio then uses a tuned circuit or tuner to select a single channel or frequency band and demodulate or decode the information from that broadcaster. If we made a graph of the strength of each channel vs. the frequency of the tuner, it would be the frequency spectrum of the antenna signal. In astronomical spectroscopy, the strength, shape, and position of absorption and emission lines, as well as the overall spectral energy distribution of the continuum, reveal many properties of astronomical objects. Stellar classification is the categorisation of stars based on their characteristic electromagnetic spectra. The spectral flux density is used to represent the spectrum of a light-source, such as a star.
Omeprazole, sold under the brand names Prilosec and Losec among others, is a medication used in the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger–Ellison syndrome. It is also used to prevent upper gastrointestinal bleeding in people who are at high risk. Omeprazole is a proton-pump inhibitor (PPI) and its effectiveness is similar to that of other PPIs. It can be taken by mouth or by injection into a vein. It is also available in the fixed-dose combination medication omeprazole/sodium bicarbonate as Zegerid and as Konvomep. Common side effects include nausea, vomiting, headaches, abdominal pain, and increased intestinal gas. Serious side effects may include Clostridioides difficile colitis, an increased risk of pneumonia, an increased risk of bone fractures, and the potential of masking stomach cancer. Whether it is safe for use in pregnancy is unclear. It works by blocking the release of stomach acid. Omeprazole was patented in 1978 and approved for medical use in 1988. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2023, it was the tenth most commonly prescribed medication in the United States, with more than 45 million prescriptions. It is also available without a prescription in the United States.
Soldiers were expected to carry their grain rations and cooking utensils in addition to their weaponry, with their backpacks potentially weighing as much as eighty pounds (36 kg). Without the hindrance of oxen and carts, this enabled Macedonian armies to move faster than their opponents. The grain provided to Macedonian soldiers would be wheat, barley, or millet, which were available throughout Asia and could be stored indefinitely when dried. The soldiers would use grinding mills carried by servants to turn the grain into flour, which could then be made into bread, biscuits, and porridge. They also ate various kinds of dried fruits such as dates and figs, which were readily available throughout much of Asia. Whenever possible, they would eat dried meat, salted fish, and shellfish. In ancient China, soldiers of the Han dynasty ate primarily millet and other grains such as wheat, rice, sorghum, etc. Grains could be eaten as a porridge, boiled, made into a bread or flatbread, smashed and fried in a manner similar to modern fried rice and fried noodles, etc. According to Zhao Chongguo, a military commander of the Han dynasty who served in the first century BC, a force of 10,281 men required 27,363 hu of grain and 308 hu of salt each month, requiring a convoy of 1,500 carts for transport. One hu is equivalent to 19.968 liters, meaning that each soldier would have required 51.9 liters of grain and 0.6 liters of salt per month. Another document at Juyan suggests 3.2 hu, or 63.8 liters, of grain.
power reactors are intended to produce heat for nuclear power, either as part of a generating station or a local power system such as a nuclear submarine. research reactors are intended to produce neutrons and/or activate radioactive sources for scientific, medical, engineering, or other research purposes. breeder reactors are intended to produce nuclear fuels in bulk from more abundant isotopes. The better known fast breeder reactor makes 239Pu (a nuclear fuel) from the naturally very abundant 238U (not a nuclear fuel). Thermal breeder reactors previously tested using 232Th to breed the fissile isotope 233U (thorium fuel cycle) continue to be studied and developed. While, in principle, all fission reactors can act in all three capacities, in practice the tasks lead to conflicting engineering goals and most reactors have been built with only one of the above tasks in mind. (There are several early counter-examples, such as the Hanford N reactor, now decommissioned). As of 2019, the 448 nuclear power plants worldwide provided a capacity of 398 GWE, with about 85% being light-water cooled reactors such as pressurized water reactors or boiling water reactors. Energy from fission is transmitted through conduction or convection to the nuclear reactor coolant, then to a heat exchanger, and the resultant generated steam is used to drive a turbine or generator.
Sources: en.wikipedia.org
The endoplasmic reticulum (ER) is a part of a transportation system of the eukaryotic cell, and has many other important functions such as protein folding. The word endoplasmic means "within the cytoplasm", and reticulum is Latin for "little net". It is a type of organelle made up of two subunits – rough endoplasmic reticulum (RER), and smooth endoplasmic reticulum (SER). The endoplasmic reticulum is found in most eukaryotic cells and forms an interconnected network of flattened, membrane-enclosed sacs known as cisternae in the RER, and tubular structures in the SER. The membranes of the ER are continuous with the outer nuclear membrane. The endoplasmic reticulum is not found in red blood cells, or spermatozoa. There are two types of ER that share many of the same proteins and engage in certain common activities such as the synthesis of certain lipids and cholesterol. Different types of cells contain different ratios of the two types of ER depending on the activities of the cell. RER is found mainly toward the nucleus of the cell and SER towards the cell membrane or plasma membrane of the cell. The outer (cytosolic) face of the RER is studded with ribosomes that are the sites of protein synthesis. The RER is especially prominent in cells such as hepatocytes. The SER lacks ribosomes and functions in lipid synthesis but not metabolism, the production of steroid hormones, and detoxification. The SER is especially abundant in mammalian liver and gonad cells. The ER was observed by light microscopy by Charles Garnier in 1897, who coined the term ergastoplasm.
PABA and its salts are used in nutritional epidemiological studies to assess the completeness of 24-hour urine collection for the determination of urinary sodium, potassium, or nitrogen levels. The potassium salt (potassium paraaminobenzoate, "aminobenzoate potassium") is used as a drug against fibrotic skin disorders, such as Peyronie's disease, under the brand name Potaba. There is a lack of strong evidence. It is believed to work by inhibiting fibroblast glycosaminoglycan secretion and stabilizing monoamine oxidase A activity. PABA is also occasionally used in pill form by sufferers of irritable bowel syndrome to treat its associated gastrointestinal symptoms. PABA derivatives have also been proposed to function as acetylcholinesterase inhibitors in diseases that cause deficient cholinergic systems, such as Alzheimer's disease.
Mass transfer Fontalvo Alzate, Javier (2006). Design and performance of two-phase flow pervaporation and hybrid distillation process. Technische Universiteit Eindhoven, The Netherlands: JWL boekproducties. ISBN 978-90-386-3007-6. Matuschewski, Heike (2008). MSE — modified membranes in organophilic pervaporation for aromatics/aliphatics separation. www.desline.com: Desalination. Eslami, Shahabedin; Aroujalian, Abdolreza; Bonakdarpour, Babak; Raeesi, Ahamdreza (2008). "Coupling of Pervaporation system with Fermentation Process" (PDF). International Congress on Membrane and Membrane Technology (ICOM2008) Honolulu, Hawaii, USA.
The Gibson assembly method is a relatively straightforward DNA assembly method, requiring only a few additional reagents: the 5' T5 exonuclease, Phusion DNA polymerase, and Taq DNA ligase. The DNA fragments to be assembled are synthesised to have overlapping 5' and 3' ends in the order that they are to be assembled in. These reagents are mixed together with the DNA fragments to be assembled at 50 °C and the following reactions occur:
Alpha decay energy follows the same trend as for other heavy elements. The lighter astatine isotopes have quite high decay energies, which become lower as more neutrons are added, reaching a minimum at 125 neutrons (astatine-210), even though 126 (astatine-211) is the magic number. The decay energies increase much more steeply, though, on the next two steps, reaching a high at 128 neutrons where the alpha-decay product would have the magic number of 126. Here this is astatine-213, releasing the highest energy and having the shortest life (125 ns) of all the isotopes. The energy then declines again, and alpha lifetimes increase quickly, no long-lived astatine isotope exists; this happens due to the increasing role of beta decay. This decay mode is especially important for astatine: as early as 1950, it was postulated that the element has no beta-stable isotopes (i.e. ones that do not undergo beta decay at all), though nuclear mass measurements reveal that 215At is in fact beta-stable, as it has the lowest mass of all isobars with A = 215. A beta decay mode has been found for all other astatine isotopes except for 212-216At and their isomers. Among other isotopes, if they do not undergo alpha decay: astatine-210 and the lighter isotopes decay by electron capture or positron emission, 211 by electron capture only, and astatine-217 and heavier isotopes undergo β- decay. Astatine-212, 214, and 216 should be able to decay either way.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.